Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Cameron L. Groome | President, CEO & Director | 416.65k | -- | -- |
| Mr. James S. Currie | Chief Financial Officer | 266.51k | -- | -- |
| Dr. Kenneth Hughes Ph.D. | Chief Operating Officer | 266.57k | -- | -- |
| Dr. Mark Luscher Ph.D. | Senior Vice President of Scientific Affairs | 249.29k | -- | -- |
| Mr. Philip Casselli | Senior Vice President of Sales, Business Development & Marketing | 265.1k | -- | -- |
| Mr. Christopher B. Lobb | Compliance Officer, General Counsel & Secretary | -- | -- | -- |
Microbix Biosystems Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Corporate Governance
Upcoming Events
February 12, 2025 at 1:30 PM UTC - February 17, 2025 at 1:30 PM UTC
Microbix Biosystems Inc. Earnings Date
Recent Events
September 2, 1999 at 12:00 AM UTC
Ex-Dividend Date